Amphiregulin as monitoring biomarker for life-threatening acute graft-versushost disease: secondary analysis of two prospective clinical trials.

Holtan, Shernan G; El Jurdi, Najla; Rashidi, Armin; Betts, Brian C; Demorest, Connor; Galvin, John P; MacMillan, Margaret L; Weisdorf, Daniel J; Panoskaltsis-Mortari, Angela; Pratta, Michael A.

Holtan SG; University of Minnesota, Adult Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN.
El Jurdi N; University of Minnesota, Adult Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN.
Rashidi A; University of Minnesota, Adult Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN; Fred Hutchinson Cancer Center.
Betts BC; University of Minnesota, Adult Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN.
Demorest C; Biostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN.
Galvin JP; Incyte Corporation, Wilmington, DE.
MacMillan ML; University of Minnesota, Pediatric Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN.
Weisdorf DJ; University of Minnesota, Adult Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN.
Panoskaltsis-Mortari A; University of Minnesota, Pediatric Blood and Marrow Transplant and Cell Therapy Program, Minneapolis, MN.
Pratta MA; Incyte Corporation, Wilmington, DE.

Haematologica ; 2023 Sep 14.

Article en En | MEDLINE | ID: mdl-37706330

ABSTRACT

Not available.

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article